ArticleThe Journal of international medical research2026
Tislelizumab combined with gemcitabine plus cisplatin for muscle-invasive upper tract urothelial carcinoma: A retrospective single-center cohort analysis.
Jingwen Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.